AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,285 | -42.4% | 221,850 | -7.8% | 0.87% | -44.7% |
| Q2 2023 | $3,966 | +48.7% | 240,629 | -17.3% | 1.58% | +50.6% |
| Q1 2023 | $2,667 | +20.1% | 291,113 | -6.2% | 1.05% | +24.9% |
| Q4 2022 | $2,221 | -99.9% | 310,251 | -20.6% | 0.84% | +1.8% |
| Q3 2022 | $1,958,000 | +258.6% | 390,861 | +74.7% | 0.82% | +259.8% |
| Q2 2022 | $546,000 | -61.5% | 223,780 | +7.8% | 0.23% | -49.3% |
| Q1 2022 | $1,418,000 | -32.0% | 207,663 | -19.6% | 0.45% | -36.2% |
| Q4 2021 | $2,086,000 | – | 258,198 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |